Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments
| Status: | Archived |
|---|---|
| Conditions: | Colorectal Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | May 2010 |
| End Date: | August 2011 |
Pilot Study of CS-1008 in Combination With FOLFIRI (Irinotecan, Leucovorin, and 5-fluorouracil [5-FU]) in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Failed First-line Treatment That Was Not Irinotecan-based.
Treatment with CS-1008 in combination with FOLFIRI (irinotecan, leucovorin, and
5-fluorouracil [5-FU]) in subjects with metastatic colorectal cancer (CRC) who have failed
first-line treatment that was not irinotecan-based.
We found this trial at
3
sites
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials